SPharma launches business & investment solution “5 no, 8 yes”

The pharmaceutical and cosmetic market in Vietnam is an attractive destination for investors. Applying the Social Business model, the SPharma strategic project of SReal Corp brings a comprehensive business solution “5 no 8 have”, maximizing the strengths of current pharmaceutical and cosmetic business models.

The SPharma project captures the principles of pharmaceutical market business

In recent years, especially after the Covid 19 epidemic, the growth rate of the pharmaceutical industry has increased as people pay more attention to proactive health care, improve knowledge and choose effective health care products. quality products and services. In terms of long-term vision, the growth driver of the pharmaceutical industry also comes from the aging population when there are currently about 13.86 million people over the age of 60, equivalent to 13% of Vietnam’s total population. This number is forecast to increase to 23.34 million people, accounting for 21% of Vietnam’s total population by 2040. This is a good opportunity for investors to participate in the pharmaceutical market when forecasting pharmaceutical revenue. OTC channel can achieve corresponding growth from 36,700 billion VND to 50,000 billion VND in 4 years from 2022 to 2026.

According to Mr. Ta Thuy – Founder & Chairman of the Board of Directors of SReal Corp, it is very difficult to establish an exclusive brand and make an impression on users in just a short time. Furthermore, financial constraints easily cause investors to fall into ruts in production and business such as: poor quality products, goods that are difficult to circulate, and expensive costs of renting factories and warehouses. , transportation, premises and lack of effective business solutions. Not only that, pharmaceutical brands have to go through a huge network with many intermediary levels, from distributors, wholesalers, to suppliers and stores to distribute products. This operating model has many flaws such as difficulty controlling quality and easy mixing of poor products. In particular, the cost of products reaching consumers will increase proportionally to the number of intermediaries.

Mr. Ta Thuy shared about Social Business solutions for the future of the Pharmaceutical industry

Seizing the opportunity and finding a solution to the pharmaceutical business problem, the SPharma project of SReal Corp has brought a Social Business distribution solution with the comprehensive health care brand RealCare. Investors and businesses will receive maximum support on a platform with full utilities, simple and streamlined processes, and direct product distribution without having to go through any intermediaries. With the “5 no 8 yes” solution, SPharma aims to solve all difficulties, reduce pressure on marketing, promotion, communication, increase sales efficiency, optimize costs, maximize profits and ensure ensure safety for investors.

The “5 no 8 yes” solution and the Social Business model are effective in pharmaceutical business

Social impact business (Social Business) with the core foundation “People – Process – Technology” helps grow the trust of the business customer community, the circulation of goods is more convenient, and the cash flow rotates. Faster rounds, creating better community purchasing power. Investors and businesses benefit from its simplicity, ease of operation, low cost, and reduced risk. Customers have access to good products with real value along with many accompanying utilities and services.

SPharma’s “5 NO 8 YES” solution is likened to “golden insurance” for investors when participating in the pharmaceutical market. The “5 NO” here include:

NO capital: All people can participate in business completely free of charge, only use capital when they want to increase profits.
NO import of goods: Investors do not have to hold goods, SPharma supports all storage costs, allowing the exchange of items depending on business capabilities.
NO shipping: Free shipping costs from SPharma’s Standard Warehouse, ensuring quality to consumers.
Doesn’t waste time: All the most optimal processes are packaged into the software, making it easy to operate and coordinate business efficiency.
NO inventory: Balancing the investment ratio of goods sources depending on business capacity will help minimize inventory risks.

The “5 no 8” solution brings many benefits to investors and businesses

In addition, the “8 YES” solution will help make business and investment simpler, increase revenue and cash flow payments quickly, specifically:

Products with quality, reasonable price, diverse customer base, guaranteed by CVI Pharma.
There is free, methodical training on the E-Learning system.
YES Marketing – Communications builds professional strategies.
Have easy access to capital thanks to SReal’s available investment community and social energy sources.
WITH smart key account management.
There is a simple process, easy to do through the software system.
HAS high quality sources of customers.
HAVE a stable income source of 10 million/month.

The SPharma project aims to socialize the pharmaceutical business with specific goals

Thanks to the application of Social Business solutions to the distribution model on a comprehensive technology platform, SReal Corp’s SPharma project expects that by 2023 it will connect more than 1,000 distribution points, supporting more than 100,000 Social Sales with revenue. Stable income, sharing proactive health care knowledge with 10 million customers, thereby helping to solve the unemployment problem with a revenue of 1,000 billion VND. SPharma promises to be a restructuring solution for businesses, creating many jobs for workers amid the impact of the Covid-19 pandemic and the effects of the global economy in the following decades.

According to CafeF